释放长非编码RNA在膀癌中的潜力
Yoran L Tomassen1, Ewan A Gibb2, Yair Lotan3
1Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands.
Expert review of molecular diagnostics
|December 10, 2025
概括
长非编码RNAs (lncRNAs) 在膀癌 (BC) 精确瘤学方面表现有前途. 分析lncRNAs可以改善风险分层和个性化治疗强度,可能减少BC管理中的过度治疗.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 膀癌 (BC) 是一种常见的恶性瘤,复发率高.
- 目前的方法难以准确预测BC复发和进展.
- 长非编码RNAs (lncRNAs) 正在成为瘤生物学中的关键调节者.
研究的目的:
- 审查 lncRNAs 在膀癌 (BC) 中的作用.
- 探索 lncRNA 功能,预后价值和个性化治疗的潜力.
- 讨论 lncRNA 集成到临床实践中用于BC管理.
主要方法:
- 叙述对BC中lncRNAs现有文献的综述.
- 在非肌肉侵入性 (NMIBC) 和肌肉侵入性 (MIBC) 膀癌中 lncRNA 参与的分析.
- 检查分子分析研究的风险分层和治疗指南.
主要成果:
- LncRNAs影响BC细胞的增殖,迁移,EMT和治疗耐药性.
- 在BC的风险分层和分子亚型中,LncRNA分析有助于BC.
- LncRNAs为BC.提供了超越传统临床病理学参数的洞察力.
结论:
- LncRNAs代表了在膀癌中精确瘤学的有希望的途径.
- 整合lncRNA分析可以优化BC风险分层和个性化治疗强度.
- 需要进行进一步的大规模前性试验,以验证 lncRNA 签名的临床用途.
相关概念视频
02:39lncRNA - Long Non-coding RNAs
9.7K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.7K
02:39lncRNA - Long Non-coding RNAs
3.5K
3.5K
03:18Non-LTR Retrotransposons
13.1K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
13.1K